DigestRedComo funciona
Red
/
Empresas
C₂
No verificado

C₂N Diagnostics, LLC

Sobre qué escribimos

BiotecnologíaCienciaIndustriaMaterial médico sanitarioSalud

10 Comunicados de prensa

Ver todos los comunicados de prensa
13/03/2025
Mercado laboral
Material médico sanitario
Salud
Sanidad
Biotecnología
Samsung Invests in C2N Diagnostics
Fuente
C₂N Diagnostics, LLC
Editor
Business Wire
1,00
0
24/02/2025
Biotecnología
Material médico sanitario
Sanidad
Salud
Medicina - Varios
Industria
C2N Diagnostics’ PrecivityAD2™ Blood Test Receives MHRA Medical Device Certification in the United Kingdom
Fuente
C₂N Diagnostics, LLC
Editor
Business Wire
1,00
0
31/01/2025
Ciencia
Biotecnología
Sanidad
Salud
Psiquiatría
Medicina - Varios
Análisis de Mercados
Industria
Study Highlights How C2N’s PrecivityAD2™ Blood Biomarker Test Use Improves Clinical Decision-Making in the Evaluation for Alzheimer’s Disease
Fuente
C₂N Diagnostics, LLC
Editor
Business Wire
1,00
0
28/01/2025
Ciencia
Biotecnología
Material médico sanitario
Salud
Psiquiatría
Industria
First Canadian Clinic to Offer C2N’s PrecivityAD2™ Blood Test to Help Healthcare Providers Diagnose Alzheimer’s Disease, Joining Global Community in Embracing Breakthrough Technology
Fuente
C₂N Diagnostics, LLC
Editor
Business Wire
1,00
0
15/01/2025
Industria
Ciencia
Sanidad
Medicina nuclear
Asociaciones/Profesionales
Psiquiatría
Biotecnología
Medicina - Varios
Salud
C2N Diagnostics Partners with The Michael J. Fox Foundation to Uncover New Links Between Parkinson’s Disease, Lewy Body Dementia and Alzheimer’s Disease
Fuente
C₂N Diagnostics, LLC
Editor
Business Wire
1,00
0
30/09/2024
Industria
Biotecnología
Salud
Sanidad
Medicina nuclear
Psiquiatría
Ciencia
Medicina - Varios
C2N Diagnostics Receives $15 Million Program Related Investment from GHR Foundation to Develop Tau Tangle Pathology Test for Diagnosing, Staging Alzheimer’s Disease
Fuente
C₂N Diagnostics, LLC
Editor
Business Wire
1,00
0
25/09/2024
Mercado laboral
Industria
Ciencia
Biotecnología
Farmacéutica
Salud
Material médico sanitario
Medicina - Varios
C2N Receives Funding from Diagnostics Accelerator to Develop a Decentralized Clinical Mass Spectrometry Solution to Enable High-Performance Alzheimer’s Disease Testing Worldwide
Fuente
C₂N Diagnostics, LLC
Editor
Business Wire
1,00
0
07/08/2024
Material médico sanitario
Biotecnología
Salud
Tercera edad
Farmacéutica
Psiquiatría
Ciencia
Ir de compras
Mercado laboral
C2N Diagnostics and Unilabs Announce Global Partnership, Bringing Together Innovation Leaders in Diagnostics and Laboratory Medicine to Advance Brain Health
Fuente
C₂N Diagnostics, LLC
Editor
Business Wire
1,00
0
28/07/2024
Material médico sanitario
Salud
Ciencia
Biotecnología
Industria
JAMA Publishes Landmark Clinical Study Showing C2N Diagnostics’ PrecivityAD2™ Blood Test Markedly Improves Accuracy of AD Diagnosis in Both Primary Care and Specialized Memory Care
Fuente
C₂N Diagnostics, LLC
Editor
Business Wire
1,00
0
27/06/2024
Mercado laboral
Industria
Ciencia
Farmacéutica
Ir de compras
Psiquiatría
Biotecnología
Tercera edad
Material médico sanitario
Gestión empresarial
Salud
C2N’s Precivity™ Tests are Now Offered Through Mayo Clinic Laboratories
Fuente
C₂N Diagnostics, LLC
Editor
Business Wire
1,00
0

Detalles de contacto

Redes sociales

Seguidores
0
Compatibilidad
0